Mechanisms of SAMHD1-mediated HIV-1 restriction in dendritic cells

树突状细胞中 SAMHD1 介导的 HIV-1 限制机制

基本信息

  • 批准号:
    8542053
  • 负责人:
  • 金额:
    $ 36.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-17 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Immune activation is the driving force of HIV-1 replication in vivo, which facilitates viral infection in target cells and fundamentally contribute to AIDS pathogenesis. Myeloid cells, including monocytes, dendritic cells (DCs) and macrophages, play a critical role in innate immunity against viral infection. Our long-term goal is to define th mechanisms regulating immune activation of myeloid cells during HIV-1 infection. SAMHD1 is a recently identified HIV-1 restriction factor in myeloid cells. SAMHD1 a nuclear protein involved in innate immunity and has been proposed to act as a negative regulator of the interferon response. However, the role of SAMHD1 in regulating immune activation of myeloid cells remains unknown. The molecular mechanisms of SAMHD1-mediated HIV-1 restriction in DCs are not fully understood. In this project, we aim to study the mechanisms of SAMHD1-mediated HIV-1 restriction in primary DCs and the role of SAMHD1 in regulating immune activation of DCs. In our preliminary studies, we observed that HIV-1 infection of DCs significantly up-regulated the release of some early pro-inflammatory cytokines. Intriguingly, we found that HIV-1 infection of DCs resulted in the translocation of SAMHD1 from the nucleus to the cytoplasm. Our central hypotheses are: HIV-1 infection of DCs triggers SAMHD1 cytoplasmic translocation, which is important for HIV-1 restriction and immune suppression of DCs. As a result, HIV-1 restriction by SAMHD1 in DCs negatively regulates DC-mediated activation of CD4+ T-cells and HIV-1 transmission, which sets up a less permissive environment for HIV-1 spreading. We propose two specific aims to test these novel hypotheses. Aim 1. To examine the role of SAMHD1 in suppression of immune activation of DCs during HIV-1 infection; and Aim 2. To define the mechanisms of SAMHD1-mediated HIV-1 restriction in DCs. Our proposed studies will reveal the unique role of SAMHD1 in regulating immune activation of myeloid DCs during HIV-1 infection and define the precise mechanisms of SAMHD1-mediated HIV-1 restriction in primary DCs. Accomplishing the proposed studies will also elucidate the mechanisms by which SAMHD1 negatively regulates DC-mediated HIV-1 trans-infection and activation of CD4+ T-cells. Overall, our results will provide new insights into intrinsic immunity against HIV-1 infectin in myeloid DCs, which can help us to develop novel interventions to block HIV-1 infection and transmission.
描述(申请人提供):免疫激活是HIV-1在体内复制的驱动力,促进病毒感染靶细胞,从根本上促进艾滋病发病。髓系细胞包括单核细胞、树突状细胞和巨噬细胞,在抗病毒感染的先天性免疫中起关键作用。我们的长期目标是确定HIV-1感染过程中骨髓细胞免疫激活的调节机制。SAMHD 1是最近在骨髓细胞中鉴定的HIV-1限制因子。SAMHD 1是一种核蛋白, 先天性免疫,并被认为是干扰素应答的负调节剂。然而,SAMHD 1在调节骨髓细胞免疫活化中的作用仍然未知。SAMHD 1介导的HIV-1在DC中限制的分子机制尚未完全了解。本课题旨在研究SAMHD 1介导的HIV-1在原代DC中的限制性表达机制及其在调节DC免疫激活中的作用。在我们的初步研究中,我们观察到,HIV-1感染的DC显着上调释放一些早期促炎细胞因子。有趣的是,我们发现HIV-1感染DC导致SAMHD 1从细胞核易位到细胞质。我们的主要假设是:DC感染HIV-1后,SAMHD 1发生胞质转位,这对DC的HIV-1限制和免疫抑制具有重要意义。因此,DC中SAMHD 1对HIV-1的限制负调节DC介导的CD 4 + T细胞活化和HIV-1传播,这为HIV-1传播建立了一个不太允许的环境。我们提出了两个具体的目标来测试这些新的假设。目标1.研究SAMHD 1在HIV-1感染过程中抑制DC免疫激活的作用;目的2.探讨SAMHD 1介导的HIV-1在DC中的限制性表达机制。我们的研究将揭示SAMHD 1在HIV-1感染过程中调节髓样DC免疫激活的独特作用,并确定SAMHD 1介导的HIV-1限制原代DC的确切机制。完成所提出的研究还将阐明SAMHD 1负调控DC介导的HIV-1转感染和CD 4 + T细胞活化的机制。总之,我们的研究结果将为髓样DCs抗HIV-1感染的内在免疫提供新的见解,这可以帮助我们开发新的干预措施来阻断HIV-1感染和传播。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Li Wu其他文献

Li Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Li Wu', 18)}}的其他基金

Targeting HIV-1 RNA modifications in latently infected CD4+ T cells for therapeutic development
针对潜伏感染 CD4 T 细胞中的 HIV-1 RNA 修饰进行治疗开发
  • 批准号:
    10596144
  • 财政年份:
    2022
  • 资助金额:
    $ 36.07万
  • 项目类别:
Targeting HIV-1 RNA modifications in latently infected CD4+ T cells for therapeutic development
针对潜伏感染 CD4 T 细胞中的 HIV-1 RNA 修饰进行治疗开发
  • 批准号:
    10462273
  • 财政年份:
    2022
  • 资助金额:
    $ 36.07万
  • 项目类别:
Epitranscriptomic m6A profile of SARS-CoV-2-infected human lung epithelial cells
SARS-CoV-2感染的人肺上皮细胞的表观转录组m6A谱
  • 批准号:
    10412132
  • 财政年份:
    2021
  • 资助金额:
    $ 36.07万
  • 项目类别:
Epitranscriptomic m6A profile of SARS-CoV-2-infected human lung epithelial cells
SARS-CoV-2感染的人肺上皮细胞的表观转录组m6A谱
  • 批准号:
    10297640
  • 财政年份:
    2021
  • 资助金额:
    $ 36.07万
  • 项目类别:
SAMHD1-mediated regulation of HIV-1 innate immunity and viral gene expression
SAMHD1介导的HIV-1先天免疫和病毒基因表达的调节
  • 批准号:
    9987485
  • 财政年份:
    2019
  • 资助金额:
    $ 36.07万
  • 项目类别:
Mechanisms of HIV-1 RNA Methylation in Regulating Viral Replication
HIV-1 RNA甲基化调节病毒复制的机制
  • 批准号:
    10025542
  • 财政年份:
    2019
  • 资助金额:
    $ 36.07万
  • 项目类别:
SAMHD1-mediated regulation of HIV-1 innate immunity and viral gene expression
SAMHD1介导的HIV-1先天免疫和病毒基因表达的调节
  • 批准号:
    10025843
  • 财政年份:
    2019
  • 资助金额:
    $ 36.07万
  • 项目类别:
SAMHD1-mediated regulation of HIV-1 innate immunity and viral gene expression
SAMHD1介导的HIV-1先天免疫和病毒基因表达的调节
  • 批准号:
    10569509
  • 财政年份:
    2019
  • 资助金额:
    $ 36.07万
  • 项目类别:
SAMHD1-mediated regulation of HIV-1 innate immunity and viral gene expression
SAMHD1介导的HIV-1先天免疫和病毒基因表达的调节
  • 批准号:
    10337184
  • 财政年份:
    2019
  • 资助金额:
    $ 36.07万
  • 项目类别:
Mechanisms of HIV-1 RNA Methylation in Regulating Viral Replication
HIV-1 RNA甲基化调节病毒复制的机制
  • 批准号:
    9348703
  • 财政年份:
    2017
  • 资助金额:
    $ 36.07万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 36.07万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 36.07万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 36.07万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 36.07万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 36.07万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 36.07万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 36.07万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 36.07万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 36.07万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 36.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了